JUNO

Juno Therapeutics, Inc.
JUNO

Delisted

JUNO was delisted on the 5th of March, 2018.

157 hedge funds and large institutions have $1.55B invested in Juno Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 52 increasing their positions, 48 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
157
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$13.1M
Puts
$17.7M
Net Calls
Net Calls Change

Top Buyers

1 +$92.5M
2 +$18.6M
3 +$16.4M
4
Goldman Sachs
Goldman Sachs
New York
+$15.8M
5
CAM
Cormorant Asset Management
Massachusetts
+$14.4M

Top Sellers

1 -$33.5M
2 -$8.92M
3 -$4.57M
4
Citigroup
Citigroup
New York
-$3.76M
5
AQR Capital Management
AQR Capital Management
Connecticut
-$3.76M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$385M
2
$248M
3
$137M
4
$92.8M
5
$66.9M
6
$48.5M
7
$48.1M
8
$47.3M
9
$42.6M
10
$35M
11
$33.9M
12
$30.6M
13
$27.3M
14
$20.5M
15
$20.3M
16
$19.1M
17
$19.1M
18
$17.1M
19
$14.4M
20
$13.2M
21
$11.7M
22
$10.4M
23
$8.54M
24
$7.59M
25
$6.78M